Clinical Trial: Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia

Brief Summary: The purpose of this study is to determine the prevalence of positive antiphospholipid antibodies among women with preeclampsia and to determine the effect of antiphospholipid antibodies on the severity of preeclampsia and the obstetric outcomes

Detailed Summary: For all women included in the study, blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant. The clinical details of all women will be collected by reviewing their hospital and prenatal records. The following clinical characteristics will be evaluated: maternal age, previous gestations, parity, past or family history of preeclampsia, gestational age at the onset of preeclampsia, gestational age at delivery and birth weight. The following pregnancy and delivery complications will be assessed: placental insufficiency, intrauterine growth restriction, fetal loss (stillbirth) and early neonatal death.
Sponsor: Mohamed Sayed Abdelhafez

Current Primary Outcome: Rate of positive antiphospholipid antibodies [ Time Frame: 20 weeks to 42 weeks gestational age ]

Number of women having positive antiphospholipid antibodies per total number of women


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Mansoura University

Dates:
Date Received: February 26, 2016
Date Started: April 2015
Date Completion: September 2017
Last Updated: May 8, 2017
Last Verified: May 2017